Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole in Early Stage Alveolar Echinococcosis
NCT07182305Phase 2Completed
- Sponsor
- Ministry of Health of the Kyrgyz Republic
- Start
- May 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of albendazole in Alveolar echinococcosis (AE), sponsored by Ministry of Health of the Kyrgyz Republic. Started May 2017; status: completed.
02
Drugs
albendazole
03
Conditions
Alveolar echinococcosis (AE)
Beyond the preview
Go deeper on NCT07182305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07182305.